F-star Therapeutics Inc. (FSTX) Fundamentals

F-star Therapeutics Inc is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the company's goal is to offer patients greater and more durable benefits than immuno-oncology treatments.
SHARE INFORMATION
Market Cap$ 137,754,157
Shares Outstanding21,557,771
Float21,324,688
Percent Float98.92%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 21,167,000
Latest Fiscal EPS$ -2.04
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions87
Institutional Holdings Date2022-05-31
Institutional Bought Previous 3 Months94,949
Institutional Holdings Percent52.9%
Institutional Sold Previous 3 Months874,823
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months-
Insider Holdings Percent2.4
Insider Sold Previous 3 Months-
Insider Shares Owned509,360
TRADING INFO
52 Week High$ 9.38
52 Week Low$ 2.07
52 Week High Change$ -27.47
21 Day Moving Average$ 3.5976
21 Day Extended Moving Average$ 3.8431
50 Day Moving Average$ 3.1086
50 Day Extended Moving Average$ 3.4285
200 Day Moving Average$ 4.5926
200 Day Extended Moving Average$ 4.4086
10 Day Average Volume1,046,939
20 Day Average Volume598,044
30 Day Average Volume440,547
50 Day Average Volume320,322
Alpha-0.036382
Beta1.8354
Standard Deviation0.234128
R20.137812
7 Day Price Change$ 2.98
7 Day Percent Change87.39%
21 Day Price Change$ 3.12
21 Day Percent Change95.41%
30 Day Price Change$ 3.82
30 Day Percent Change148.64%
Month to Date Price Change$ 3.35
Month to Date Percent Change110.2%
Quarter to Date Price Change$ 2.84
Quarter to Date Percent Change80.0%
180 Day Price Change$ 1.04
180 Day Percent Change19.44%
200 Day Price Change$ 1.55
200 Day Percent Change32.02%
Year to Date Price Change$ 1.37
Year to Date Percent Change27.29%

F-star Therapeutics Inc. (FSTX) Key Ratios

PROFITABILITY
EBIT Margin-158.9%
EBITDA Margin-155.6%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 20,801,000
Revenue Per Share$ 0.9649
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.50
Total Debt To Equity0.20
Int Coverage-31.00
Current Ratio6.10
Leverage Ratio1.30
Quick Ratio5.80
Long Term Debt To Capital0.12
VALUATION MEASURES
PE Ratio-4.10
Enterprise Value$ 82,008,156
Price to Sales6.6225
Price to Free Cash-5.50
PE High Last 5 Years0.00
Price To Book1.60
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book2.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover5.50
Invoice Turnover0.00
Assets Turnover0.20
Return Assets-40.73
Return on Equity-55.57
Return on Capital-46.41

F-star Therapeutics Inc. (FSTX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorRSM US LLP
CEOEliot Richard Forster
Emplyoees88
Last AuditUE
CIK0001566373
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
AddressBabraham Research Campus
Eddeva B920
Cambridge, CB22 3AT
Websitehttps://www.f-star.com
Facsimile-
Telephone+44 1223497400
Email-
Your Recent History
NASDAQ
FSTX
F star The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220628 07:14:16